Letrozole Accelerates Metabolic Remodeling through Activation of Glycolysis in Cardiomyocytes: A Role beyond Hormone Regulation

Estrogen receptor-positive (ER+) breast cancer patients are recommended hormone therapy as a primary adjuvant treatment after surgery. Aromatase inhibitors (AIs) are widely administered to ER+ breast cancer patients as estrogen blockers; however, their safety remains controversial. The use of letroz...

Descripción completa

Detalles Bibliográficos
Autores principales: Heo, Jun H., Lee, Sang R., Jo, Seong Lae, Yang, Hyun, Lee, Hye Won, Hong, Eui-Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745349/
https://www.ncbi.nlm.nih.gov/pubmed/35008972
http://dx.doi.org/10.3390/ijms23010547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745349/
https://www.ncbi.nlm.nih.gov/pubmed/35008972
http://dx.doi.org/10.3390/ijms23010547

Ejemplares similares